Please Note: This trial is no longer enrolling new participants
A Randomized, Open-Label, Phase 2 Study Evaluating Abemaciclib in Combination with Irinotecan and Temozolomide in Participants with Relapsed or Refractory Ewing's Sarcoma.
| Protocol No. | PHO-LILLY-J1S-MC-JP04 | Scope | National |
|---|---|---|---|
| Principal Investigator | Marissa Just | Treatment Type | Treatment |
| Age Group | Adults and Children | Phase | Phase II |
